Partnership broadens precision medication entry on the level of care with seamless ordering and receipt of Caris molecular profiling outcomes straight in affected person data by way of the OncoEMR® platform
IRVING, Texas, Sept. 23, 2022 /PRNewswire/ — Caris Life Sciences®(Caris), the main molecular science and know-how firm actively creating and delivering modern options to revolutionize healthcare, at the moment introduced a partnership with Flatiron Well being, a healthtech firm devoted to serving to most cancers facilities thrive and ship higher take care of sufferers, to combine Caris’ market main molecular testing portfolio with OncoEMR®, a number one cloud-based digital medical file (EMR) software.
“The combination with OncoEMR is one other milestone achievement alongside our purpose of creating customized precision healthcare accessible to as many physicians and sufferers as attainable,” mentioned David Spetzler, M.S., Ph.D., MBA, President and Chief Scientific Officer of Caris. “Delivering essential molecular outcomes straight on the level of care in group oncology settings is paramount to each affected person’s skill to battle, and hopefully beat most cancers. Integrating inside the OncoEMR platform, which reaches virtually 40 p.c of all U.S. group oncologists, considerably aids in delivering on our dedication.”
The Molecular Profiling Integration between OncoEMR and Caris allows data-driven medical determination making for over 2,000 clinicians inside the Flatiron community, made up of greater than 800 distinctive most cancers care places throughout the nation. By means of the Molecular Profiling Integration, customers can simply submit Caris orders with fewer clicks and fewer knowledge entry, observe real-time standing updates, and obtain the outcomes straight inside OncoEMR. This streamlines medical workflows for physicians and gives entry to Caris molecular studies in the identical atmosphere during which they develop care plans. Along with presenting time-saving advantages inside the clinician ordering course of, the cloud-based integration is well enabled–with no related value or improvement work–to any follow within the Flatiron community that wishes it.
“Perception into tumor biology allows precision medication, and this Molecular Profiling Integration with Caris permits oncologists and their groups to effectively order molecular profiling exams, observe order standing and look at outcomes, all with out leaving OncoEMR. Simplifying the workflow can promote acceptable and equitable testing, eradicate redundant exams, reduce follow disruption, and floor therapeutic alternatives with the purpose of higher affected person outcomes,” mentioned James Hamrick, Vice President Medical Oncology at Flatiron Well being. “We’re thrilled for this partnership with Caris to additional improve delivering a greater care expertise for physicians and their sufferers, as we reimagine the infrastructure of most cancers care.”
Caris’ complete suite of molecular profile companies, together with complete entire exome and entire transcriptome sequencing, is now obtainable for ordering inside the OncoEMR community. Caris is the primary and solely companion with entire exome and entire transcriptome sequencing capabilities to combine with Flatiron’s OncoEMR and plans to proceed collaborating with EMR/EHR techniques throughout each educational and group oncology areas on new methods to combine genomic outcomes into affected person care and schooling.
About Caris Life Sciences
Caris Life Sciences® (Caris) is the main molecular science and know-how firm actively creating and delivering modern options to revolutionize healthcare and enhance affected person outcomes. By means of complete molecular profiling (Complete Exome and Complete Transcriptome Sequencing) and the applying of superior synthetic intelligence (AI) and machine studying algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing wanted to investigate and unravel the molecular complexity of illness. This info gives an unmatched useful resource and the perfect path ahead to conduct the essential, elementary analysis to speed up discovery for detection, analysis, monitoring, remedy choice and drug improvement to enhance the human situation.
With a major give attention to most cancers, Caris’ suite of market-leading molecular profiling choices assesses DNA, RNA and proteins to disclose a molecular blueprint that helps sufferers, physicians and researchers higher detect, diagnose and deal with sufferers. Caris’ newest development is a blood-based, circulating nucleic acids sequencing (cNAS) assay that mixes complete molecular evaluation (Complete Exome and Complete Transcriptome Sequencing from blood) and serial monitoring – making it essentially the most highly effective liquid biopsy assay ever developed.
Headquartered in Irving, Texas, Caris has places of work in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris gives companies all through the U.S., Europe, Asia and different worldwide markets. To be taught extra, please go to CarisLifeSciences.com or comply with us on Twitter (@CarisLS).
About Flatiron Well being
Flatiron Well being is a healthtech firm devoted to serving to most cancers facilities thrive and ship higher take care of sufferers at the moment and tomorrow. By means of medical and knowledge science, we translate affected person experiences into real-world proof to enhance remedy, inform coverage, and advance analysis. Most cancers is sensible. Collectively, we will be smarter. Flatiron Well being is an unbiased affiliate of the Roche Group. Flatiron.com @FlatironHealth
Caris Life Sciences Media Contact:
Flatiron Media Contact:
SOURCE Caris Life Sciences